+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Transport of fluorescein in MDCKII-MRP1 transfected cells and mrp1-knockout mice



Transport of fluorescein in MDCKII-MRP1 transfected cells and mrp1-knockout mice



Biochemical and Biophysical Research Communications 284(4): 863-869



The multidrug resistant-associated protein 1 (MRP1) is a membrane-bound transport protein that is involved in the efflux of organic anions and has been implicated in multidrug resistance in cancer. MRP1 has also been reported to be ubiquitously expressed in normal tissues, including the brain. The presence of functional organic anion transporters in the blood-brain and blood-CSF barriers that influence the distribution of various compounds to the brain has long been known. The purpose of this study was to examine the role of MRP1 in the brain distribution of a model organic anion, fluorescein. The substrate specificity of MRP1 for fluorescein was initially determined by examining the accumulation of fluorescein in MDCKII MRP1-transfected cells. The distribution of fluorescein in the brain was then examined in wild-type and mrp1 gene knockout mice. The results show that in MDCKII MRP1-transfected cells, the accumulation of fluorescein was significantly lower (about 40% lower) than that in wild-type MDCKII cells. MRP1 inhibitors such as probenecid, MK-571, and LY402913 enhanced fluorescein accumulation in MDCKII MRP1-transfected cells to a greater extent than in wild-type MDCKII cells. In an in vivo study, after intravenous injection of fluorescein, the fluorescein brain-to-plasma concentration ratio in mrp1 knockout mice was not significantly different than that in wild-type mice. However, when probenecid was co-administered with fluorescein in wild-type mice, the fluorescein brain-to-plasma ratio was significantly increased (1.5-fold). These findings suggest that fluorescein is a substrate for MRP1. Furthermore, the in vivo study also suggests that MRP1 has a limited role in the transport and distribution of fluorescein in the brain. Therefore, other organic anion transport proteins, including the various isoforms of the MRP family, may be responsible for the accumulation and transport of organic anions in the brain.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 011589021

Download citation: RISBibTeXText

PMID: 11409873

DOI: 10.1006/bbrc.2001.5062


Related references

Expression of P-glycoprotein, multidrug-resistance proteins 1 and 2 in CEM, CEM(VBL), CEM(E1000), MDCKII(MRP1) and MDCKII(MRP2) cell lines. Aids 17(15): 2276-2278, 2003

Mechanistic differences between GSH transport by multidrug resistance protein 1 (MRP1/ABCC1) and GSH modulation of MRP1-mediated transport. Molecular Pharmacology 74(6): 1630-1640, 2008

Down-Regulation of MRP1 Expression in C6/VP16 Cells by Chitosan-MRP1-siRNA Nanoparticles. Cell Biochemistry and Biophysics 72(1): 227-233, 2015

Functional characterization of canine MRP1 in HeLa and A2780 cells and its modulation by MRP1 modulator Ly402913. Proceedings of the American Association for Cancer Research Annual Meeting 42: 952, 2001

Mrp1 modulators synergize with buthionine sulfoximine to exploit collateral sensitivity and selectively kill Mrp1-expressing cancer cells. Biochemical Pharmacology 168: 237-248, 2019

Hypoxia can impair doxorubicin resistance of non-small cell lung cancer cells by inhibiting MRP1 and P-gp expression and boosting the chemosensitizing effects of MRP1 and P-gp blockers. Cellular Oncology 39(5): 411-433, 2016

Novel bicistronic retroviral vector expressing gamma-glutamylcysteine synthetase and the multidrug resistance protein 1 (MRP1) protects cells from MRP1-effluxed drugs and alkylating agents. Human Gene Therapy 12(14): 1785-1796, 2001

MRP1-transfected cells do not show increased resistance against oxidative stress. Free Radical Research 37(2): 189-195, 2003

Coordinated action of glutathione S-transferases (GSTs) and multidrug resistance protein 1 (MRP1) in antineoplastic drug detoxification. Mechanism of GST A1-1- and MRP1-associated resistance to chlorambucil in MCF7 breast carcinoma cells. Journal of Biological Chemistry 273(32): 20114-20120, 1998

Effect of selective and novel MRP1 modulators on the transporter activity of MRP1. Proceedings of the American Association for Cancer Research Annual Meeting 42: 949, 2001

In vivo analysis of human multidrug resistance protein 1 (MRP1) activity using transient expression of fluorescently tagged MRP1. Cancer Research 62(2): 391-396, 2002

Frequency of MRP1 genetic polymorphisms and their functional significance in Caucasians: detection of a novel mutation G816A in the human MRP1 gene. European Journal of Clinical Pharmacology 59(4): 347-350, 2003

Deletion of the multidrug resistance protein 1 (MRP1) gene in acute myeloid leukemia patients with inversion 16: expression of MRP1 homologues. Leukemia 15(1): 191-192, 2001

The use of mrp1-deficient (Danio rerio) zebrafish embryos to investigate the role of Mrp1 in the toxicity of cadmium chloride and benzo[a]pyrene. Aquatic Toxicology 186: 123-133, 2017

Idarubicin is a poor substrate for MRP1 Characterization of the drug-resistance profile in a doxorubicin-resistant U-1285 cell line with an elevated MRP1 expression. Blood 98(11 Part 2): 179b, 2001